Royalty Pharma plc recently raised its quarterly dividend for the first quarter of 2026 to US$0.235 per Class A ordinary share, a 6.8% increase over the prior quarter, and set payment for March 10, ...
Analysts on Wall Street project that Royalty Pharma (RPRX) will announce quarterly earnings of $1.10 per share in its forthcoming report, representing an increase of 14.6% year over year. Revenues are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results